Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

502
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
502
Analgesia and Pain Management01:25

Analgesia and Pain Management

923
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
923
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

450
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
450
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

2.3K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.3K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

793
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
793
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

140
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
140

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Opioid Cage in Survivorship: Avoidance Learning and the Legacy Opioid Patient.

Journal of pain and symptom management·2026
Same author

From Symptom Control to Precision Supportive Oncology: Integrating Artificial Intelligence in Supportive Oncology for Gastrointestinal Cancers.

Current oncology reports·2026
Same author

Substance use monitoring in supportive oncology: surveillance is not a clinical outcome, and policing is not a therapeutic framework.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Routine Urine Drug Screening in Palliative Care - A Call for Evidence Before Implementation.

Journal of pain and symptom management·2026
Same author

Does the Edmonton Symptom Assessment Scale rule in or rule out anxiety and depression?

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

MASCC score and neutropenic complications: what is the likelihood?

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Related Experiment Video

Updated: Oct 13, 2025

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat
13:27

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat

Published on: October 6, 2018

8.3K

Treating Chronic Pain with Buprenorphine-The Practical Guide.

Amy A Case1, Justin Kullgren2, Sidra Anwar3

  • 1Lee Foundation Endowed Chair Supportive and Palliative Care, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. amy.case@roswellpark.org.

Current Treatment Options in Oncology
|November 18, 2021
PubMed
Summary

Buprenorphine is a safe and effective first-line option for chronic pain management, particularly in the elderly. It offers benefits over traditional opioids, including reduced side effects and lower misuse potential.

Keywords:
BuprenorphineChronic painMicrodosingOpioid

More Related Videos

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
04:13

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models

Published on: September 27, 2024

497
Author Spotlight: Investigating Cellular and Molecular Dynamics During Muscle Regeneration Using Cutting-Edge Single-Cell Technologies
11:02

Author Spotlight: Investigating Cellular and Molecular Dynamics During Muscle Regeneration Using Cutting-Edge Single-Cell Technologies

Published on: December 1, 2023

1.2K

Related Experiment Videos

Last Updated: Oct 13, 2025

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat
13:27

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat

Published on: October 6, 2018

8.3K
Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
04:13

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models

Published on: September 27, 2024

497
Author Spotlight: Investigating Cellular and Molecular Dynamics During Muscle Regeneration Using Cutting-Edge Single-Cell Technologies
11:02

Author Spotlight: Investigating Cellular and Molecular Dynamics During Muscle Regeneration Using Cutting-Edge Single-Cell Technologies

Published on: December 1, 2023

1.2K

Area of Science:

  • Pharmacology
  • Pain Management
  • Addiction Medicine

Background:

  • Buprenorphine possesses unique pharmacological properties beneficial for various clinical applications.
  • Traditional opioid analgesics carry risks, including cognitive impairment, falls, sexual dysfunction, and sarcopenia, especially in elderly populations.

Purpose of the Study:

  • To highlight the advantages of buprenorphine as a first-line treatment for chronic pain.
  • To discuss its utility in patients with substance use disorders or at risk of opioid misuse.
  • To emphasize its growing popularity and safety profile for analgesia.

Main Methods:

  • Review of pharmacological properties of buprenorphine.
  • Comparison of buprenorphine with Schedule II opioids for chronic pain.
  • Analysis of buprenorphine's role in managing opioid use disorder.

Main Results:

  • Buprenorphine is associated with fewer adverse effects like cognitive impairment, falls, and sexual dysfunction compared to Schedule II opioids.
  • It presents a lower risk of misuse and euphoria, potentially improving mood in patients.
  • Recent regulatory changes have removed training and waiver requirements for prescribing buprenorphine for opioid use disorder.

Conclusions:

  • Buprenorphine is a recommended first-line opioid for chronic pain, especially in the elderly, due to its favorable side effect profile.
  • Its efficacy in managing opioid use disorder and lower misuse potential make it a valuable therapeutic option.
  • Practitioners should consider buprenorphine as a safe and effective choice for chronic pain management.